- Results from the largest European and first multicenter, retrospective, observational chart review study investigating the real-world use of ECP in heart transplant patients reinforce its
VASCEPA Approved by the National Medical Products Administration as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia EddingPharm Now. | June 1, 2023
VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (= 500 mg/dL)
Lawmakers are playing another game of brinksmanship as the nation's ability to pay its bills nears its limit. GFOA's Emily Brock discusses how a failure to reach a compromise could be a serious blow for municipal issuers. Kyle Glazier hosts.
This meta-analysis pools data from 7 randomized trials to estimate the association between administration of corticosteroids vs usual care or placebo and all-ca